Back to Journals » Patient Preference and Adherence » Volume 16

Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence

Total article views   HTML views PDF downloads Totals
9,988 Dovepress* 8,750+ 330 9,080
PubMed Central* 1,238 259 1,497
Totals 9,988 589 10,577
*Since 24 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 4 5

View citations on PubMed Central and Google Scholar